United States - English - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - dinoprostone 10 mg in 241 mg

United States - English - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - dinoprostone 10 mg in 241 mg - cervidil is indicated for the initiation and/or continuation of cervical ripening in pregnant women at or near term in whom there is a medical or obstetrical indication for the induction of labor. cervidil is contraindicated in patients with: - known hypersensitivity to prostaglandins [see adverse reactions (6.2)] - evidence or clinical suspicion of fetal distress where delivery is not imminent - unexplained vaginal bleeding in the current pregnancy - evidence or clinical suspicion of marked cephalopelvic disproportion - conditions for which induction of labor is contraindicated - conditions for which oxytocic drugs are contraindicated - previous cesarean section or other uterine surgery expected to affect uterine integrity (such as myomectomy) - conditions under which prolonged contraction of the uterus may be detrimental to fetal safety - concurrent use with intravenous oxytocic agents [see warnings and precautions (5.4) and drug interactions (7)] - six or more previous term pregnancies risk summary cervidi

United States - English - NLM (National Library of Medicine)

pharmacia and upjohn company llc - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - dinoprostone 0.5 mg in 3 g - prepidil gel is indicated for ripening an unfavorable cervix in pregnant women at or near term with a medical or obstetrical need for labor induction. endocervically administered prepidil gel is not recommended for the following: - cases with a history of cesarean section or major uterine surgery - cases in which cephalopelvic disproportion is present - cases in which there is a history of difficult labor and/or traumatic delivery - grand multiparae with six or more previous term pregnancies cases with non-vertex presentation - cases with hyperactive or hypertonic uterine patterns - cases of fetal distress where delivery is not imminent - in obstetric emergencies where the benefit-to-risk ratio for either the fetus or the mother favors surgical intervention no drug abuse or drug dependence has been seen with the use of prepidil gel.

United States - English - NLM (National Library of Medicine)

pharmacia and upjohn company llc - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - - prostin e2 vaginal suppository is indicated for the termination of pregnancy from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period. - prostin e2 is also indicated for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period. - prostin e2 is indicated in the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole). - hypersensitivity to dinoprostone [see warnings and adverse reactions] - acute pelvic inflammatory disease - patients with active cardiac, pulmonary, renal, or hepatic disease

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - dinoprostone, quantity: 10 mg - pessary - excipient ingredients: hexanetriol/macrogol 8000/isocyanate cross linked hydrogel copolymer - cervical ripening in patients, at or near term, who have favourable induction features and in whom there is a medical or obstetrical indication for induction of labour.

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - dinoprostone - pessary - dinoprostone 10 mg - dinoprostone - dinoprostone - initiation and/or continuation of cervical ripening in patients at term, from 38th week of gestation, with bishop score of 6 or less.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dinoprostone - solution for injection - dinoprostone 10 mg/ml - dinoprostone - dinoprostone - therapeutic termination of pregnancy, missed abortion.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dinoprostone - gel - dinoprostone 0.033 %w/w - dinoprostone - dinoprostone - for labour induction in term and near term pregnant women who have favorable induction features and who have a singleton pregnancy with vertex presentation

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dinoprostone - gel - dinoprostone 0.066 %w/w - dinoprostone - dinoprostone - for labour induction in term and near term pregnant women who have favorable induction features and who have a singleton pregnancy with vertex presentation

Canada - English - Health Canada

pfizer canada ulc - dinoprostone - gel - 1mg - dinoprostone 1mg - oxytocics